Table 2.
General characteristics of participants according to the application type
| Sociodemographic factor | NCSPa) (%) (n=1,185) | Medical Aid (n=760) | Lung cancer (n=585) | Childhood cancerb) (n=170) | Total (n=2,700) | p-value |
|---|---|---|---|---|---|---|
| Sex | ||||||
| Male | 572 (48.3) | 384 (50.5) | 394 (67.4) | 96 (56.5) | 1,446 (53.6) | - |
| Female | 613 (51.7) | 376 (49.5) | 191 (32.6) | 74 (43.5) | 1,254 (46.4) | |
| Total | 1,185 (43.8) | 760 (28.1) | 585 (21.6) | 170 (6.3) | 2,700 (100) | |
| Age (yr) | ||||||
| < 50 | 88 (7.4) | 83 (10.9) | 19 (3.3) | 170 (100) | 360 (13.3) | < 0.001 |
| 50-59 | 308 (25.9) | 144 (19.0) | 92 (15.7) | 0 | 544 (20.1) | |
| 60-69 | 472 (39.8) | 200 (26.3) | 220 (37.6) | 0 | 892 (33.0) | |
| ≥ 70 | 317 (26.8) | 333 (43.8) | 254 (43.4) | 0 | 904 (33.5) | |
| Total | 1,185 (43.8) | 760 (28.1) | 585 (21.6) | 170 (6.3) | 2,700 (100) | |
| Location | ||||||
| Metropolitan city | 539 (45.5) | 359 (47.2) | 235 (40.2) | 60 (35.3) | 1,193 (44.2) | - |
| Province | 646 (54.5) | 401 (52.8) | 350 (59.8) | 110 (64.7) | 1,507 (55.8) | |
| Total | 1,185 (43.8) | 760 (28.1) | 585 (21.6) | 170 (6.3) | 2,700 (100) | |
| Registration type | ||||||
| New | 297 (36.0) | 217 (42.9) | 159 (44.8) | 42 (36.5) | 715 (39.7) | - |
| Old | 527 (63.9) | 289 (57.1) | 196 (55.2) | 73 (63.5) | 1,085 (60.3) | |
| Total | 824 (45.8) | 506 (28.1) | 355 (19.7) | 115 (6.4) | 1,800 (100) | |
| Education | ||||||
| Below middle school | 522 (45.0) | 434 (58.3) | 339 (59.4) | 59 (35.3) | 1,354 (50.2) | < 0.001 |
| Middle to high school | 453 (39.1) | 234 (31.4) | 174 (30.5) | 49 (29.3) | 910 (33.7) | |
| College or higher | 184 (15.9) | 77 (10.3) | 58 (10.2) | 59 (35.3) | 378 (14.0) | |
| Total | 1,159 (43.9) | 745 (28.2) | 571 (21.6) | 167 (6.3) | 2,642 (100) | |
| Income (KRW)c) | ||||||
| < 1 million | 461 (55.9) | 446 (88.1) | 250 (70.4) | 19 (16.5) | 1,176 (65.3) | < 0.001 |
| 1 million-3 million | 303 (36.8) | 56 (11.1) | 86 (24.2) | 80 (69.6) | 525 (29.2) | |
| > 3 million | 60 (7.2) | 4 (0.8) | 19 (5.4) | 16 (13.9) | 99 (5.5) | |
| Total | 824 (45.8) | 506 (28.1) | 355 (19.7) | 115 (6.4) | 1,800 (100) | |
| Private insurance | ||||||
| No | 430 (36.3) | 574 (75.5) | 316 (54.0) | 61 (35.9) | 1,381 (51.2) | < 0.001 |
| Yes | 755 (63.7) | 186 (24.5) | 269 (46.0) | 109 (64.1) | 1,319 (48.9) | |
| Total | 1,185 (43.8) | 760 (28.1) | 585 (21.6) | 170 (6.3) | 2,700 (100) | |
| Cancer stage | ||||||
| 1 | 505 (45.4) | 249 (40.2) | 181 (33.8) | 15 (21.1) | 950 (40.6) | < 0.001 |
| 2-3 | 534 (47.9) | 262 (42.3) | 228 (42.6) | 25 (35.2) | 1,049 (44.9) | |
| 4 | 74 (6.7) | 109 (17.6) | 126 (23.6) | 31 (43.6) | 340 (14.5) | |
| Total | 1,113 (45.6) | 620 (26.5) | 535 (22.9) | 71 (3.0) | 2,339 (100) |
a)
NCSP, patients diagnosed by National Cancer Screening Program,
b)
Childhood cancer, parents of childhood cancer patients,
c)
Average monthly income.